Impact d'un traitement avec fenofibrate ou atorvastatin sur la cinétique in vivo de la protéine C-réactive

Impact d'un traitement avec fenofibrate ou atorvastatin sur la cinétique in vivo de la protéine C-réactive

Show other versions (1)

Tableau d’honneur de la Faculté des études supérieures et postdoctorales, 2008-2009 === Les travaux de maîtrise présentés dans ce mémoire ont permis d'évaluer le métabolisme in vivo de la protéine C-réactive (CRP) chez des patients diabétiques de type 2, en réponse à un traitement avec le fenof...

Full description

Bibliographic Details
Main Author:	Lévesque, Josée
Other Authors:	Lamarche, Benoît
Format:	Dissertation
Language:	French
Published:	Université Laval 2009
Subjects:	Protéine C-réactive > Métabolisme Fénofibrate Atorvastatine Diabète non insulinodépendant > Physiopathologie
Online Access:	http://hdl.handle.net/20.500.11794/20689

Similar Items

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia
by: Meenakshi Lella, et al.
Published: (2013-01-01)

Combination of atorvastatin and fenofibrate altered androgenic activities of male rats
by: Kawa F. Dizaye, et al.
Published: (2019-08-01)

Impact d'un traitement avec fenofibrate ou atorvastatin sur la cinétique in vivo de la protéine C-réactive
by: Lévesque, Josée
Published: (2009)

Influences génétiques de la réponse lipidique à un traitement au fénofibrate
by: Brouillette, Charles
Published: (2006)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
by: Mostafa Najafipour, et al.
Published: (2018-01-01)

Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: A randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
by: Omar ePatiño-Rodríguez, et al.
Published: (2015-01-01)

Impact du diabète et de l'obésité sur la pathologie Tau dans la maladie d'Alzheimer
by: Gratuze, Maud
Published: (2017)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01)

Evaluating efficacy and safety of differential therapy with atorvastatin, fenofibrate and their combination in patients with type 2 diabetes
by: G. A. Batrak
Published: (2015-12-01)

Étude de la voie des polyols dans le placenta en prééclampsie
by: Routhier, Catherine
Published: (2014)

Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
by: Rayan G. Alamri, et al.
Published: (2017-01-01)

Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
by: Hanmant Barkate, et al.
Published: (2018-01-01)

Fenofibrate-induced renal dysfunction, yes or no?
by: Fatemeh Emami, et al.
Published: (2020-01-01)

Étude de la régulation de l'expression des récepteurs de l'interleukine-1 dans l'endomètre de femmes avec et sans endométriose
by: Bellehumeur, Christian
Published: (2010)

Influence du contenu en macronutriments d'un repas préalable, standardisé, sur la réponse glycémique et insulinique suite à un exercice de type aérobie chez la femme diabétique de type 2 postménopausée
by: Bonneville, Nadine
Published: (2009)

Le traitement du diabète de type 2 chez les moins de 65 ans : description et qualité du traitement
by: Ben Abdeljelil, Anis
Published: (2009)

Effect of Fenofibrate on Neonatal Hyperbilirubinemia: A Systematic Review and Meta-analysis
by: Nasrin Zamiri-Miandoab, et al.
Published: (2021-07-01)

Fenofibrate and Crataegus oxyacantha is an effectual combo for mixed dyslipidemia
by: Huda A Rasheed, et al.
Published: (2020-01-01)

Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
by: Olga Nikolaevna Tkacheva, et al.
Published: (2010-03-01)

Influence du profil lipidique maternel sur l'expression de récepteurs à lipoprotéine de faible densité
by: Éthier Chiasson, Maude
Published: (2007)

Investigation of parent-of-origin effects induced by fenofibrate treatment on triglycerides levels
by: Chloé Sarnowski, et al.
Published: (2018-09-01)

A Rare Cause of Acute Renal Failure: Fenofibrate-Induced Rhabdomyolysis
by: Ferhat Icme, et al.
Published: (2013-08-01)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
by: Moloud Kazemi, et al.
Published: (2018-01-01)

Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit
by: Fayeza Mohammed, et al.
Published: (2017-11-01)

Impact des désordres métaboliques et rôle de l'inflammation dans la physiopathologie de la sténose aortique
by: Côté, Claude
Published: (2008)

Detecting responses to treatment with fenofibrate in pedigrees
by: Svetlana Cherlin, et al.
Published: (2018-09-01)

The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas
by: Wei Zhu, et al.
Published: (2021-06-01)

Impact du diabète de type 2 bien contrôlé et sans complications cardiovasculaires sur la consommation d'oxygène, la cinétique de la consommation d'oxygène et la cinétique de la fréquence cardiaque
by: Caron, Joanie
Published: (2013)

The Effect of Oral Fenofibrate on Serum Bilirubin Level in Term Neonates with Hyperbilirubinemia: A Randomized Clinical Trail
by: Mousa Ahmadpour-kacho, et al.
Published: (2018-10-01)

Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials
by: Ye Jiatao, et al.
Published: (2011-09-01)

Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement
by: Bhavesh D. Kevadiya, et al.
Published: (2018-02-01)

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2014-09-01)

Preparation and pharmacokinetic study of fenofibrate cubic liquid crystalline
by: Shijie Wei, et al.
Published: (2017-11-01)

Fenofibrate protects endothelial cells against the harmful effects of TNF-alpha
by: Westcott, Corli, et al.
Published: (2017-04-01)

Étude pharmacogénétique d'un hypolipémiant
by: Tojcic, Jelena
Published: (2009)

Assessment of Adding Fenofibrate to Simvastatin on Exercise Test Findings in Patients with Dyslipidemia and Coronary Artery Disease
by: Reza Karbasi Afshar, et al.
Published: (2013-12-01)

Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate
by: Yousaf AM, et al.
Published: (2016-01-01)

High-performance liquid chromatography and derivative spectrophotometry for simultaneous determination of pravastatin and fenofibrate in the dosage form
by: Hefnawy Mohamed M., et al.
Published: (2014-12-01)